Related Experiment Videos
[Left ventricular hypertrophy in patient on dialysis]
Vesna Lovcić1, D Sebetić, M Klobucić
1Centar za dijalizu Opća bolnica Bjelovar Mihanovićeva 8 43 000 Bjelovar. petar.lovcic@bj.hinet.hr
Summary
Left ventricular hypertrophy (LVH) is common in dialysis patients, particularly those with hypertension. Managing hypertension and anemia is crucial to reduce LVH risk and improve outcomes in this population.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Context:
- Cardiovascular diseases are the leading cause of death in hemodialysis patients (45%).
- Left ventricular hypertrophy (LVH) is a significant predictor of mortality in this population.
- Hypertension and anemia are identified as primary risk factors for LVH development.
Purpose:
- To investigate the relationship between hypertension, anemia, and left ventricular hypertrophy (LVH) in patients undergoing chronic dialysis.
- To analyze the correlation between LVH and clinical parameters including blood pressure and hemoglobin levels.
Summary:
- The study included 40 dialysis patients, measuring left ventricle mass index (LVMI) via echocardiography.
- Hypertension was more prevalent in males, while LVH was more common in females.
- LVMI was significantly higher in hypertensive patients, with a positive correlation between LVMI and arterial pressure, and a negative correlation with hemoglobin concentration.
Impact:
- Results indicate a strong association between hypertension and LVH in dialysis patients.
- The findings underscore the need for improved therapeutic strategies to mitigate LVH risk factors.
- Reducing LVH prevalence can potentially decrease mortality rates in patients on chronic dialysis.